Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc. (INMB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q8-K10-K8-K10-Q10-Q10-K10-Q
Net income  -6.5-6.5-5.8-7.7-6.8-6.9-9.7-9.5
Stock-based compensation  1.91.71.81.91.91.51.51.6
Change in working capital   [+]1.4-2.79.60.8-0.5-3.55.3-1.4
Other operating activities  0.16.4-11.31.70.60.0-6.91.3
Cash from operations  -3.2-1.1-5.7-3.4-4.8-8.9-9.8-7.9
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Purchases of intangible assets        -15.0 
Other cash from investing        15.0 
Cash from investing  0.00.00.00.00.00.00.00.0
   
Issuance of common stock, net       0.7 51.8
Option exercises         1.1
Other cash from financing  15.0    0.0 2.3
Cash from financing  15.00.00.00.00.00.70.052.9
   
Free cash flow  -3.2-1.1-5.7-3.4-4.8-8.9-9.8-7.9
        Per share (diluted)  ($0.18)($0.06)($0.32)($0.19)($0.27)($0.50)($0.61)($0.46)
   
Cash paid for interest  0.9 0.4 0.30.30.30.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy